From: Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study
A. SNVs + indels (dominant) | ||||||||||
Proband_ID | Sex | Gene | Position (hg19) | Position (hg38) | Inheritance | Variant type | HGVS.c | HGVS.p | Relevant OMIM phenotypes | ACMG |
BRK-48–01 | M | WDR37 | chr10:1,126,397 | chr10:1,080,457 | De novo | Dmiss | c.377A > T | p.Tyr126Phe | Neurooculocardiogenitourinary syndrome (AD) | LP |
BRK-52–01 | F | STAG1 | chr3:136,192,388 | chr3:136,473,546 | De novo | Dmiss | c.1118G > A | p.Arg373Gln | Intellectual developmental disorder (AD) | P |
BRK-98–01 | F | SCN2A | chr2:166,245,634 | chr2:165,389,124 | De novo | Dmiss | c.5318C > T | p.Ala1773Val | Developmental and epileptic encephalopathy (AD) | P |
BRK-78–01 | M | KDM5B | chr1:202,746,168 | chr1:202,777,040 | De novo | Dmiss | c.259A > T | p.Ile87Phe | Intellectual developmental disorder (AR) | LP |
BRK-11–01 | F | KCNMA1 | chr10:78,647,208 | chr10:76,887,450 | De novo | frameshift | c.3526dupA | p.Met1176fs | Paroxysmal nonkinesigenic dyskinesia with or without generalized epilepsy (AD) | LP |
BRK-86–01 | M | EIF5A | chr17:7,214,392 | chr17:7,311,073 | De novo | Dmiss | c.221C > T | p.Pro74Leu | Faundes-Banka syndrome (AD) | LP |
BRK-73–01 | M | MTOR | chr1:11,217,287 | chr1:11,157,230 | De novo | Dmiss | c.4391A > G | p.Asp1464Gly | Smith-Kingsmore syndrome (AD) | LP |
BRK-77–01 | M | GRIN2B | chr12:13,769,471 | chr12:13,616,537 | De novo | Dmiss | c.1246 T > C | p.Phe416Leu | Intellectual developmental disorder with or without seizures (AD) | LP |
sBRK-05–01 | M | MYO5A | chr15:52,676,446 | chr15:52,384,249 | De novo | Dmiss | c.1826G > A | p.Arg609His | Griscelli syndrome, type 1 (AR) | LP |
BRK-13–01, | M, | DNM1 | chr9:130,982,567 | chr9:128,220,288 | Paternal | Dmiss | c.796C > T | p.Arg266Cys | Developmental and epileptic encephalopathy (AD) | VUS |
BRK-13–04, | M, | |||||||||
BRK-13–05 | F | |||||||||
B. SNVs + indels (recessive) | ||||||||||
Proband-ID | Sex | Gene | Position (hg19) | Position (hg38) | Inheritance | Variant type | HGVS.c | HGVS.p | Relevant OMIM phenotypes | ACMG |
BRK-87–01 | M | NBN | chr8:90,983,432 | chr8:89,971,204 | HOM | Dmiss | c.671G > A | p.Gly224Glu | Nijmegen breakage syndrome (AR) | VUS |
BRK-88–01 | F | TRAPPC9 | chr8:141,370,230 | chr8:140,360,131 | HOM | Stop gain | c.1708C > T | p.Arg570* | Intellectual developmental disorder (AR) | P/LP |
BRK-54–01 | F | TSEN2 | chr3:12,544,783 | chr3:12,503,284 | HOM | Dmiss | c.331G > A | p.Ala111Thr | Pontocerebellar hypoplasia type 2B (AR) | VUS |
BRK-57–01 | F | UBR1 | chr15:43,347,084 | chr15:43,054,886 | HOM | Dmiss | c.1295 T > C | p.Ile432Thr | Johanson-Blizzard syndrome (AR) | VUS |
BRK-58–01 | M | MED17 | chr11:93,523,767 | chr11:93,790,601 | HOM | Dmiss | c.445A > G | p.Lys149Glu | Microcephaly, postnatal progressive, with seizures and brain atrophy (AR) | VUS |
BRK-59–01 | M | TIAM1 | chr21:32,513,486 | chr21:31,141,168 | HOM | Dmiss | c.3724G > A | p.Gly1242Arg | Neurodevelopmental disorder with language delay and seizures (AR) | VUS |
BRK-74–01 | M | CTSA | chr20:44,523,322 | chr20:45,894,683 | HOM | Dmiss | c.865G > C | p.Gly289Arg | Galactosialidosis (AR) | VUS |
ZNF335 | chr20:44,578,150 | chr20:45,949,511 | HOM | Dmiss | c.3727G > T | p.Val1243Leu | Microcephaly (AR) | VUS | ||
C. SNVs + indels (X-linked) | ||||||||||
Proband-ID | Sex | Gene | Position (hg19) | Position (hg38) | Inheritance | Variant type | HGVS.c | HGVS.p | Relevant OMIM phenotypes | ACMG |
BRK-41–01 | M | PTCHD1 | chrX:23,353,126 | chrX:23,335,009 | X-linked | Dmiss | c.134G > A | p.Arg45His | Autism, susceptibility to, X-linked | VUS |
BRK-43–01 | M | DMD | chrX:32,663,098 | chrX:32,644,981 | X-linked | Dmiss | c.1132C > G | p.Gln378Glu | Duchenne muscular dystrophy, syndromic ASD | VUS |
BRK-56–01 | M | SLC9A6 | chrX:135,080,654 | chrX:135,998,495 | X-linked | Dmiss | c.617G > A | p.Arg206Gln | Intellectual developmental disorder, X-linked | VUS |
BRK-76–01 | M | WNK3 | chrX:54,278,075 | chrX:54,251,642 | X-linked | Dmiss | c.2413G > C | p.Glu805Gln | Intellectual disability | VUS |
BRK-96–01 | M | WNK3 | chrX:54,337,648 | chrX:54,311,215 | X-linked | Dmiss | c.614A > G | p.Asn205Ser | Intellectual disability | VUS |
D. CNVs | ||||||||||
Proband_ID | Sex | Gene/s | Genomic disorder/cytoband | Type | Inheritance | Variant type | Size (kb) | Relevant phenotypes | ACMG | |
BRK-81–01 | M | Multiple | 22q11.21 | CNVs | De novo | Deletion | 1400 | Autism | P | |
BRK-65–01 | M | Multiple | 16p13.3 | CNVs | Maternal | Duplication | 1700 | Autism | VUS | |
E. TREs | ||||||||||
Proband_ID | Sex | Gene | Position (hg19) | Position (hg38) | Type | Inheritance | Variant type | Motif (TREs) | Relevant phenotypes | Â |
BRK-51–01 | F | SHANK2 | chr11:70,749,120–70749713 | chr11:70,903,015–70903608 | TREs | Dominant | intronic | AAAAT | Autism | |
BRK-89–01 | F | NCOR2 | chr12:124,876,767–124,877,620 | chr12:124,392,221–124,393,074 | TREs | Dominant | intronic | ACAGAGAGACAGGGAGGAG;ACAGGGAGACAGGGAGGAG | - | |
F. mtDNA | ||||||||||
Proband-ID | Sex | Gene | Variant | Proband Heteroplasmy | Maternal Heteroplasmy | Disorder | Â | |||
BRK-16–01 | M | MT-TL1 | 3243A > G | 2.1% | Undetectable | MELAS |